» Articles » PMID: 22961059

Stromal Cells Expressing Hedgehog-interacting Protein Regulate the Proliferation of Myeloid Neoplasms

Overview
Journal Blood Cancer J
Date 2012 Sep 11
PMID 22961059
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant reactivation of hedgehog (Hh) signaling has been described in a wide variety of human cancers including cancer stem cells. However, involvement of the Hh-signaling system in the bone marrow (BM) microenvironment during the development of myeloid neoplasms is unknown. In this study, we assessed the expression of Hh-related genes in primary human CD34(+) cells, CD34(+) blastic cells and BM stromal cells. Both Indian Hh (Ihh) and its signal transducer, smoothened (SMO), were expressed in CD34(+) acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)-derived cells. However, Ihh expression was relatively low in BM stromal cells. Remarkably, expression of the intrinsic Hh-signaling inhibitor, human Hh-interacting protein (HHIP) in AML/MDS-derived stromal cells was markedly lower than in healthy donor-derived stromal cells. Moreover, HHIP expression levels in BM stromal cells highly correlated with their supporting activity for SMO(+) leukemic cells. Knockdown of HHIP gene in stromal cells increased their supporting activity although control cells marginally supported SMO(+) leukemic cell proliferation. The demethylating agent, 5-aza-2'-deoxycytidine rescued HHIP expression via demethylation of HHIP gene and reduced the leukemic cell-supporting activity of AML/MDS-derived stromal cells. This indicates that suppression of stromal HHIP could be associated with the proliferation of AML/MDS cells.

Citing Articles

Downregulation of Hedgehog Interacting Protein (HHIP) in Gastric Cancer: Implications for Tumorigenesis.

Akhtar K, Rashid G, Rather T, Maqbool I, Parveiz I, Bhat G Indian J Clin Biochem. 2025; 40(1):46-58.

PMID: 39835242 PMC: 11741958. DOI: 10.1007/s12291-024-01293-x.


Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers.

Giallongo S, Duminuco A, Dulcamare I, Zuppelli T, La Spina E, Scandura G Biomolecules. 2023; 13(12).

PMID: 38136573 PMC: 10741414. DOI: 10.3390/biom13121701.


Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies.

Jing J, Wu Z, Wang J, Luo G, Lin H, Fan Y Signal Transduct Target Ther. 2023; 8(1):315.

PMID: 37596267 PMC: 10439210. DOI: 10.1038/s41392-023-01559-5.


The hedgehog pathway in hematopoiesis and hematological malignancy.

Lemos T, Merchant A Front Oncol. 2022; 12:960943.

PMID: 36091167 PMC: 9453489. DOI: 10.3389/fonc.2022.960943.


Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia-From bench to bedside.

Tesanovic S, Krenn P, Aberger F Front Cell Dev Biol. 2022; 10:944760.

PMID: 35990601 PMC: 9388743. DOI: 10.3389/fcell.2022.944760.


References
1.
Martin S, Sato N, Dhara S, Chang R, Hustinx S, Abe T . Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther. 2005; 4(7):728-33. DOI: 10.4161/cbt.4.7.1802. View

2.
Fabiani E, Leone G, Giachelia M, DAlo F, Greco M, Criscuolo M . Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. Leuk Lymphoma. 2010; 51(12):2275-84. DOI: 10.3109/10428194.2010.528093. View

3.
Dierks C, Beigi R, Guo G, Zirlik K, Stegert M, Manley P . Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008; 14(3):238-49. DOI: 10.1016/j.ccr.2008.08.003. View

4.
Clement V, Sanchez P, De Tribolet N, Radovanovic I, Ruiz i Altaba A . HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007; 17(2):165-72. PMC: 1855204. DOI: 10.1016/j.cub.2006.11.033. View

5.
Ward P, Patel J, Wise D, Abdel-Wahab O, Bennett B, Coller H . The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 2010; 17(3):225-34. PMC: 2849316. DOI: 10.1016/j.ccr.2010.01.020. View